Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
Crossref DOI link: https://doi.org/10.1007/s43441-020-00112-8
Published Online: 2020-01-13
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sharma, Atul
Khante, Shyam
Mahadik, Kakasaheb R.
Gaikwad, Vinod L. http://orcid.org/0000-0002-3368-4467
Text and Data Mining valid from 2020-01-13
Version of Record valid from 2020-01-13
Article History
Received: 1 May 2019
Accepted: 31 July 2019
First Online: 13 January 2020